Lactulose
Cat.No:IL0010 Solarbio
CAS:4618-18-2
Molecular Formula:C12H22O11
Molecular Weight:342.3
Storage:Powder:2-8℃,2 years;Insolvent(Mother Liquid):-20℃,6 months;-80℃,1 year
Purity:HPLC≥98%
Appearance:White to off-white Solid
Qty:
Size:
{{cart_num}}
My CartCAS:4618-18-2
Molecular Formula:C12H22O11
Molecular Weight:342.3
Storage:Powder:2-8℃,2 years;Insolvent(Mother Liquid):-20℃,6 months;-80℃,1 year
Purity:HPLC≥98%
Appearance:White to off-white Solid
Qty:
Size:
CAS | 4618-18-2 |
Name | Lactulose |
Molecular Formula | C12H22O11 |
Molecular Weight | 342.3 |
Solubility | Soluble in Water |
Purity | HPLC≥98% |
Appearance | White to off-white Solid |
Storage | Powder:2-8℃,2 years;Insolvent(Mother Liquid):-20℃,6 months;-80℃,1 year |
EC | EINECS 225-027-7 |
MDL | MFCD00151469 |
SMILES | OCC([C@H]([C@@H]([C@@H](CO)O)O[C@H]1[C@@H]([C@H]([C@H]([C@@H](CO)O1)O)O)O)O)=O |
InChIKey | JCQLYHFGKNRPGE-FCVZTGTOSA-N |
InChI | InChI=1S/C12H22O11/c13-1-4-6(16)7(17)8(18)11(21-4)22-9-5(2-14)23-12(20,3-15)10(9)19/h4-11,13-20H,1-3H2/t4-,5-,6+,7+,8-,9-,10+,11+,12-/m1/s1 |
PubChem CID | 3872 |
Target Point | Others |
Passage | Others |
Background | It is a disaccharide composed of galactose and fructose. |
Unit | Bottle |
Specification | 100mg 10mM*1mL in Water |
Remark:These protocols are for reference only. Solarbio does not independently validate these methods.
Note:
1. The products are all for scientific research use only. Do not use it for medical, clinical diagnosis or treatment, food and cosmetics, etc. Do not store them in ordinary residential areas.
2. For your safety and health, please wear laboratory clothes, disposable gloves and masks.
3. The experimental results may be affected by many factors, after-sale service is limited to the product itself and does not involve other compensation.
Sorry, there is no more information.
Inhibitory Effect of Lactococcus lactis subsp. lactis HFY14 on Diphenoxylate-Induced Constipation in Mice by Regulating the VIP-cAMP-PKA-AQP3 Signaling Pathway
Click to check >>Author:Tan Q; Hu J; Zhou Y; Wan Y; Zhang C; Liu X; Long X; Tan F; Zhao X.
IF:4.8000
Publish_to:Drug Design Development and Therapy
PMID:34007157